Skip to main content

roche-logo

Swiss pharmaceutical group Roche hopes to obtain fast-track US approval for a rapid diagnostic test for Ebola, its director general said in an interview published Sunday, amid the worst-ever outbreak of the killer disease.

The diagnostic test is ready for use in scientific research but the company now wants to register it for clinical use.

{iframe}http://news.yahoo.com/roche-seeks-fast-track-us-okay-ebola-diagnostic-153514549.html{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.